These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23780984)

  • 1. Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.
    Gotanda Y; Akagi Y; Kawahara A; Kinugasa T; Yoshida T; Ryu Y; Shiratsuchi I; Kage M; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2941-7. PubMed ID: 23780984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
    Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
    Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
    Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
    Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
    Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
    Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
    Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
    Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Yeh YS; Chang YT; Yang IP; Lin CH; Kuo CH; Juo SH; Wang JY
    J Surg Oncol; 2013 Feb; 107(2):148-54. PubMed ID: 22926658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
    Izumi H; Takahashi M; Uramoto H; Nakayama Y; Oyama T; Wang KY; Sasaguri Y; Nishizawa S; Kohno K
    Cancer Sci; 2011 May; 102(5):1007-13. PubMed ID: 21306479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer.
    Abe Y; Nakayama Y; Katsuki T; Inoue Y; Minagawa N; Torigoe T; Higure A; Sako T; Nagata N; Hirata K
    Asia Pac J Clin Oncol; 2019 Apr; 15(2):e49-e55. PubMed ID: 30270512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.
    Yan P; Li YH; Tang ZJ; Shu X; Liu X
    Asian Pac J Cancer Prev; 2014; 15(20):8923-9. PubMed ID: 25374230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
    Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma.
    Ono T; Miki C
    Am J Gastroenterol; 2000 Apr; 95(4):1062-7. PubMed ID: 10763960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer.
    Kurahara H; Takao S; Kuwahata T; Nagai T; Ding Q; Maeda K; Shinchi H; Mataki Y; Maemura K; Matsuyama T; Natsugoe S
    Ann Surg Oncol; 2012 Jul; 19(7):2264-71. PubMed ID: 22350599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
    Ochiumi T; Tanaka S; Oka S; Hiyama T; Ito M; Kitadai Y; Haruma K; Chayama K
    Int J Oncol; 2004 Mar; 24(3):539-47. PubMed ID: 14767538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
    Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S
    Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.